A Phase I/II Study of Lenalidomide in Patients With AIDS-Associated Kaposi's Sarcoma
Phase of Trial: Phase I/II
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Kaposi's sarcoma
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2016 Status changed from active, no longer recruiting to completed.
- 10 Oct 2013 Planned end date changed from 1 Nov 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 23 Aug 2013 Planned end date changed from 1 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.